HF
ACIU icon

HRT Financial’s AC Immune ACIU Stock Holding History

HRT Financial’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47K Buy
+17,276
New +$53.6K ﹤0.01% 3461
2022
Q2 		– Sell
-10,520
Closed -$42K – 2846
2022
Q1 		$42K Buy
+10,520
New +$45.6K ﹤0.01% 2762
2021
Q3 		– Sell
-18,878
Closed -$149K – 3216
2021
Q2 		$149K Buy
+18,878
New +$130K ﹤0.01% 2489
2020
Q1 		– Sell
-22,354
Closed -$190K – 719
2019
Q4 		$190K Buy
+22,354
New +$149K 0.01% 954

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HRT Financial's ACIU Position: Q1 2026 in Review

HRT Financial opened a new position in AC Immune (ACIU) in Q1 2026: 17,276 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #3461 among its holdings. This is a return to the name: HRT Financial previously reported a position in ACIU as recently as Q1 2022.

HRT Financial first reported a position in ACIU in Q4 2019 and has held it in 4 quarters since. The position peaked at $190K in Q4 2019. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • HRT Financial held 17,276 shares of AC Immune worth $47K as of Q1 2026.
  • AC Immune was a new HRT Financial position in Q1 2026.
  • AC Immune made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3461 holding.
  • HRT Financial first reported a position in AC Immune in Q4 2019 and has held it in 4 quarters since.
  • HRT Financial's AC Immune position peaked at $190K in Q4 2019.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.